Biotechnology
Latest quoted price for the name. Helps anchor the setup in today’s market level.
Health Entry- Stoke Therapeutics, Inc. Biotechnology STOK$26.13 64 Health 64 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Novavax, Inc. Biotechnology NVAX$10.02 62 Health 62 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Nurix Therapeutics, Inc. Biotechnology NRIX$26.70 61 Health 61 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- NewAmsterdam Pharma Company N.V. Biotechnology NAMS$20.50 60 Health 60 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Crinetics Pharmaceuticals Inc Biotechnology CRNX$84.95 59 Health 59 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Zymeworks Inc. Biotechnology ZYME$28.85 58 Health 58 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Intellia Therapeutics, Inc. Biotechnology NTLA$12.28 56 Health 56 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Iovance Biotherapeutics, Inc. Biotechnology IOVA$14.58 55 Health 55 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Celldex Therapeutics, Inc. Biotechnology CLDX$30.15 52 Health 52 / 100
Weaker fundamentals relative to higher-quality names in the universe.
Watch WatchWorth tracking, but timing is mixed — not a clear setup yet.
- Monte Rosa Therapeutics, Inc. Biotechnology GLUE$10.66 52 Health 52 / 100
Weaker fundamentals relative to higher-quality names in the universe.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.